GIA
LGND icon

GHP Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

GHP Investment Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317 Hold
1
– – ﹤0.01% 1129
2026
Q1 		$200 Buy
+1
New +$198 ﹤0.01% 1213
2024
Q3 		– Sell
-57
Closed -$4.8K – 1034
2024
Q2 		$4.8K Buy
+57
New +$4.54K ﹤0.01% 780

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GHP Investment Advisors's LGND Position: Q2 2026 in Review

GHP Investment Advisors held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 1 share worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

GHP Investment Advisors first reported a position in LGND in Q2 2024 and has held it in 3 quarters since. The position peaked at $4.8K in Q2 2024. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • GHP Investment Advisors held 1 share of Ligand Pharmaceuticals worth $317 as of Q2 2026.
  • GHP Investment Advisors left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1129 holding.
  • GHP Investment Advisors first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • GHP Investment Advisors's Ligand Pharmaceuticals position peaked at $4.8K in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.